Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) Financials
Newest figures come from the 20-F for FY2025, filed Mar 26, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AEFC SEC filings page.
This page shows Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 passes 4 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass.
For every $1 of reported earnings, Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 generates $0.44 in operating cash flow ($509.3M OCF vs $1.1B net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 reported $1.1B in net income in fiscal year 2025. This represents an increase of 61.0% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 generated $461.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 37.3% from the prior year.
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 held $3.2B in cash against $2.3B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's ROE was 10.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.9 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 invested $48.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 8.9% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
AEFC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $22.8B-4.4% | $23.9B-8.4% | $26.1B-17.6% | $31.7B-4.4% | $33.1B-16.4% | $39.6B+11.6% | $35.5B-3.5% | $36.8B |
| Operating Income | N/A | N/A | N/A | -$37.6B-234.4% | $28.0B+27.3% | $22.0B-44.7% | $39.7Bn/m | -$13.4B | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A | -$37.4B-227.7% | $29.3B+28.2% | $22.8B-44.3% | $41.1Bn/m | -$11.9B | N/A | N/A | N/A |
| Interest Expense | $103.3M-47.5% | $196.7M-2.3% | $201.3M+3.4% | $194.7M+164.7% | $73.6M-37.3% | $117.4M-58.5% | $282.9M-17.7% | $343.7M+1.0% | $340.2M+53.5% | $221.6M-15.0% | $260.6M |
| Income Tax | $76.3Mn/m | -$16.6Mn/m | -$231.2M-404.4% | $76.0M-29.4% | $107.5Mn/m | -$410.9M-268.7% | $243.6M+445.3% | $44.7M-42.8% | $78.1M-56.9% | $181.5Mn/m | -$90.1M |
| Net Income | $1.1B+61.0% | $712.1Mn/m | -$198.0Mn/m | -$609.8M-127.2% | $2.2Bn/m | -$178.6M-112.9% | $1.4B+71.4% | $808.8M-72.8% | $3.0B+543.7% | $461.1Mn/m | -$469.1M |
| EPS (Basic) | $0.69+80.8% | $0.38n/m | -$0.13n/m | -$0.32-130.2% | $1.06n/m | -$0.11-117.5% | $0.63+89.3% | $0.33-75.8% | $1.37+765.8% | $0.16 | -$0.29 |
| EPS (Diluted) | N/A | $0.38n/m | -$0.13n/m | -$0.32-130.2% | $1.06n/m | -$0.11-117.5% | $0.63+89.3% | $0.33-75.8% | $1.37+765.8% | $0.16 | -$0.29 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Diluted Shares (Avg).
AEFC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $372.3B+9.9% | $338.9B+1.6% | $333.6B-18.1% | $407.3B-23.1% | $530.0B-2.4% | $542.8B+9.9% | $493.7B+9.8% | $449.8B-5.5% | $476.0B+6.0% | $448.9B | N/A |
| Cash & Equivalents | $3.2B-10.7% | $3.6B-20.3% | $4.5B-50.4% | $9.1B+16.4% | $7.8B-23.8% | $10.2B-25.6% | $13.8B+37.4% | $10.0B-22.6% | $12.9B+8.1% | $12.0B+14.9% | $10.4B |
| Goodwill | $367.3M+2.9% | $357.1M+10.9% | $321.9M-4.8% | $338.1M-23.6% | $442.5M-3.5% | $458.6M+4.2% | $440.1M0.0% | $439.9M+24.9% | $352.2M+13.5% | $310.2M-85.0% | $2.1B |
| Total Liabilities | $361.2B+9.7% | $329.2B+1.9% | $323.0B-18.3% | $395.6B-20.9% | $500.1B-2.4% | $512.6B+9.9% | $466.3B+10.0% | $424.0B-5.2% | $447.0B+5.6% | $423.2B | N/A |
| Long-Term Debt | $2.3B-25.4% | $3.1B+19.7% | $2.6B-16.0% | $3.1B-69.0% | $10.0B+8.0% | $9.3B+90.2% | $4.9B-60.2% | $12.2B-14.8% | $14.4B+20.9% | $11.9B | N/A |
| Total Equity | $11.0B+16.1% | $9.5B-8.8% | $10.4B-9.4% | $11.5B-61.2% | $29.6B-1.5% | $30.1B+9.7% | $27.4B+6.2% | $25.8B-10.9% | $29.0B+12.8% | $25.7B-10.0% | $28.5B |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Retained Earnings.
AEFC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $509.3M-35.4% | $788.7M-17.5% | $955.8M-66.6% | $2.9Bn/m | -$2.0Bn/m | -$3.5B-142.6% | $8.2B+1284.1% | $592.3M-10.9% | $664.8M-81.0% | $3.5B+252.9% | $992.5M |
| Depreciation & Amortization | N/A | N/A | -$180.3M-199.7% | $180.8M-86.3% | $1.3B+49.6% | $883.0M-33.6% | $1.3B-11.8% | $1.5B+60.4% | $938.9M-26.3% | $1.3B-22.7% | $1.6B |
| Capital Expenditures | $48.1M-8.9% | $52.8M-26.6% | $71.9M-6.7% | $77.0M-10.5% | $86.0M-12.1% | $97.8M-14.6% | $114.5M+23.4% | $92.8M+7.2% | $86.6M+18.9% | $72.8M-25.5% | $97.7M |
| Free Cash Flow | $461.2M-37.3% | $736.0M-16.7% | $883.9M-68.2% | $2.8Bn/m | -$2.1Bn/m | -$3.6B-144.4% | $8.1B+1518.4% | $499.5M-13.6% | $578.3M-83.1% | $3.4B+283.3% | $894.8M |
| Investing Cash Flow | $1.2B+281.7% | $310.5Mn/m | -$2.2B-381.6% | $784.2Mn/m | -$61.1Mn/m | -$170.0Mn/m | -$96.6Mn/m | -$501.8Mn/m | -$1.4Bn/m | -$1.1B-270.3% | $667.8M |
| Financing Cash Flow | -$2.4Bn/m | -$1.8Bn/m | -$3.6Bn/m | -$2.0B-677.8% | $339.5Mn/m | -$951.5Mn/m | -$4.2Bn/m | -$2.7B-539.7% | $623.9Mn/m | -$490.7Mn/m | -$3.0B |
| Dividends Paid | $699.5M+29.7% | $539.3M-1.3% | $546.5M+205.9% | $178.7M+30.5% | $136.9M+77.7% | $77.0M-77.8% | $346.9M-7.7% | $375.8M+6.3% | $353.4M+9.5% | $322.9M+1.8% | $317.1M |
Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.
AEFC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | N/A | -164.7% | 117.2% | 84.3% | 125.5% | -40.5% | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | -2.7%-12.1pp | 9.4%+10.1pp | -0.7%-5.1pp | 4.4%+1.9pp | 2.4%-5.0pp | 7.5%+6.2pp | 1.3%+2.6pp | -1.3% |
| Return on Equity | 10.4%+2.9pp | 7.5%+9.4pp | -1.9%+3.4pp | -5.3%-12.9pp | 7.6%+8.2pp | -0.6%-5.7pp | 5.1%+1.9pp | 3.1%-7.1pp | 10.3%+8.4pp | 1.8%+3.5pp | -1.7% |
| Return on Assets | 0.3%+0.1pp | 0.2%+0.3pp | -0.1%+0.1pp | -0.1%-0.6pp | 0.4%+0.4pp | 0.0%-0.3pp | 0.3%+0.1pp | 0.2%-0.4pp | 0.6%+0.5pp | 0.1% | N/A |
| Debt-to-Equity | 0.21-0.1x | 0.33+0.1x | 0.250.0x | 0.27-0.1x | 0.340.0x | 0.31+0.1x | 0.18-0.3x | 0.470.0x | 0.500.0x | 0.46 | N/A |
| Liabilities-to-Equity | 32.70-1.9x | 34.62+3.6x | 30.98-3.4x | 34.37+17.5x | 16.88-0.2x | 17.050.0x | 17.01+0.6x | 16.43+1.0x | 15.44-1.1x | 16.49 | N/A |
| Asset Turnover | N/A | N/A | N/A | 0.060.0x | 0.040.0x | 0.050.0x | 0.060.0x | 0.070.0x | 0.080.0x | 0.08 | N/A |
| FCF Margin | N/A | N/A | N/A | 12.2%+21.1pp | -8.9%+4.9pp | -13.8%-39.3pp | 25.5%+24.0pp | 1.5%+0.1pp | 1.5%-8.2pp | 9.7%+7.2pp | 2.4% |
Not reported in any period shown, so not listed: Gross Margin, Current Ratio.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin.
Where Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 Ranks
Frequently Asked Questions
Is Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 profitable?
Yes, Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) reported a net income of $1.1B in fiscal year 2025.
How much debt does Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 have?
As of fiscal year 2025, Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) had $3.2B in cash and equivalents against $2.3B in long-term debt.
What is Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's return on equity (ROE)?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) has a return on equity of 10.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's free cash flow?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) generated $461.2M in free cash flow during fiscal year 2025. This represents a -37.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's operating cash flow?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) generated $509.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's total assets?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) had $372.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's capital expenditures?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) invested $48.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's debt-to-equity ratio?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) had a debt-to-equity ratio of 0.21 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's liabilities-to-equity ratio?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) had a liabilities-to-equity ratio of 32.70 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's return on assets (ROA)?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) had a return on assets of 0.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's Piotroski F-Score?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) has a Piotroski F-Score of 4 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aegon Funding Company LLC 5.10% Subordinated Notes due 2049's earnings high quality?
Aegon Funding Company LLC 5.10% Subordinated Notes due 2049 (AEFC) has an earnings quality ratio of 0.44x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.